These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37694062)

  • 41. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Proposed Grading System and Experience of COVID-19 Associated Rhino Orbito Cerebral Mucormycosis from an Indian Tertiary Care Center.
    Vaid N; Mishra P; Gokhale N; Vaid S; Vaze V; Kothadiya A; Deka T; Agarwal R
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3505-3512. PubMed ID: 34804905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rhino Orbital Cerebral Mucormycosis in Covid-19 Crisis.
    Vadivel S; Gowrishankar M; Vetrivel K; Sujatha B; Navaneethan P
    Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):1014-1020. PubMed ID: 36855632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhino-Orbital-Cerebral Mucormycosis in a Young Diabetic Patient with COVID-19 in Ethiopia: A Case Report.
    Alemayehu FM; Abate HK; Soboka TA; Huluka DK; Worke AB; Abrie MT; Dibaba DK; Asnake YB
    Int Med Case Rep J; 2022; 15():251-257. PubMed ID: 35615254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retrospective analysis of the role of retrobulbar amphotericin-B injection in the management of COVID-19 associated rhino-orbito-cerebral-mucormycosis.
    Yadav R; Madan S; Rohatgi J; Ansari A; Sharma R; Gautam P; Rai P; Das GK; Sahu PK; Arora V
    Pan Afr Med J; 2022; 42():312. PubMed ID: 36451988
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post surgical immediate prosthetic reconstruction in patients with rhinocerebral mucormycosis: Case series.
    Mahajan K; Das M; Kumar GA
    J Family Med Prim Care; 2022 Jan; 11(1):379-385. PubMed ID: 35309624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Imaging Spectrum Along With Other Diagnostic Modalities in Rhino-Orbital-Cerebral Mucormycosis (ROCM).
    Meena V; Barath S; Singh S; Jakhar P; Patel T
    Cureus; 2024 Feb; 16(2):e53962. PubMed ID: 38469024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fungal Endophthalmitis in a Case of Rhino-Orbito-Cerebral Mucormycosis: Successfully Treated With Amphotericin B Colloidal Dispersion.
    Zhao Y; Tian W; Yang J; Li X; Lu H; Yu N; Zhang P; Liu C; Chen P; Lei G; Liu Y
    Front Microbiol; 2022; 13():910419. PubMed ID: 35783387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rhino-orbito-cerebral mucormycosis: an epidemic in a pandemic.
    Sekaran A; Patil N; Sabhapandit S; Sistla SK; Reddy DN
    IJID Reg; 2022 Mar; 2():99-106. PubMed ID: 35721429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rhino-orbital and rhino-orbito-cerebral mucormycosis.
    Talmi YP; Goldschmied-Reouven A; Bakon M; Barshack I; Wolf M; Horowitz Z; Berkowicz M; Keller N; Kronenberg J
    Otolaryngol Head Neck Surg; 2002 Jul; 127(1):22-31. PubMed ID: 12161726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prosthetic rehabilitation of intraoral defects in patients with rhino-orbital-cerebral-mucormycosis: A systematic review.
    Wadhwa S; Mathew RS; Daniel AY; Kurian N; Varghese KG
    J Indian Prosthodont Soc; 2024 Jan; 24(1):36-45. PubMed ID: 38263556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19.
    Shakrawal J; Sharma V; Goyal A; Kumar D; Meena S; Tiwari S; Jain V; Elhence P; Soni K; Choudhury B; Bhatnagar K; Garg MK; Misra S
    Int Ophthalmol; 2023 Jun; 43(6):1919-1926. PubMed ID: 36427099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spectrum of magnetic resonance imaging findings in post-COVID-19 patients presenting with rhino-orbito-cerebral mucormycosis in a teaching hospital in Malwa region of Punjab.
    Singh P; Kaur K; Jindal V; Kaur M; Kaur M; Singh N
    J Family Med Prim Care; 2022 Dec; 11(12):7788-7794. PubMed ID: 36994047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perioperative anesthesia challenges and outcomes of patients with Rhino-Orbito-Cerebral Mucormycosis during the second wave of COVID-19 pandemic: An observational study.
    Kumari K; Rathod D; Meshram T; Mohammed S; Raju S; Sharma A; Chaudhary B; Bhatia P
    J Anaesthesiol Clin Pharmacol; 2023; 39(4):615-621. PubMed ID: 38269163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiological Manifestations of Rhino-Orbito-Cranial Mucormycosis in COVID-19 Patients Correlated With Pathological and Clinical Outcomes and Emphasis on Magnetic Resonance Imaging-Based Scoring System.
    Patil C; Kumar A; Battula V; Kumar P; Kollu R; Kotamraju S; Nethi Balingari BL; Reddy S; Ravula S; Reddy AR
    Cureus; 2023 Mar; 15(3):e35745. PubMed ID: 37020477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
    Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
    Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Case of Bilateral Central Retinal Artery Occlusion in a Post-COVID Rhino-Orbital-Cerebral Mucormycosis Patient.
    Patnaik A; Sharma B; Ahmad R; Kumar A; Chitrotpala R; Gupta M
    Cureus; 2021 Nov; 13(11):e20062. PubMed ID: 35003938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rhino-Orbital Cerebral Mucormycosis in Non-Diabetic Patients with COVID-19.
    Elhamamsy S; Bayer T; Al-Kaffas M; Hatahet S; Grover M; Samdhani S; Nanda A; Gravenstein S
    R I Med J (2013); 2021 Oct; 104(8):19-21. PubMed ID: 34582509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rhino-orbital-cerebral mucormycosis in times of COVID-19: A neurosurgical experience.
    Singh H; Dua S; Goel A; Dhar A; Bhadauria V; Garg A; Katyar V; Sharma S; Shukla A
    Surg Neurol Int; 2021; 12():538. PubMed ID: 34754588
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjunctive use of saturated solution of potassium iodide (SSKI) with liposomal amphotericin B (L-AMB) in mucormycosis achieves favorable response, shortened dose and duration of amphotericin: A retrospective study from a COVID-19 tertiary care center.
    Mrig S; Sardana K; Arora P; Narula V; Arora S; Kapoor A; Baruah RR; Sen P; Agarwal S; Sachdeva S; Dewan A; Panesar S
    Am J Otolaryngol; 2022; 43(3):103465. PubMed ID: 35429848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.